cenobamate
cenobamate: 3 clinical trials tracked.
cenobamate evidence translation
What we can confirm
3 tracked trials
What it means
What to watch
Prepared research question
What is verified about cenobamate, and what remains unknown?
Traceable citations · Unknowns marked
Clinical Trial Registry Records (3)
Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy
Primary endpoint: Seizure-freedom during the 26-week Maintenance Phase of the 100 mg/day Treatment Period
Open-Label Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures
Primary endpoint: Incidence of Adverse Events and SAEs
A Phase I, Open-Label, Pharmacokinetic, Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures
Primary endpoint: The area under the curve (AUC) of Xcopri after a single and multiple doses of Xcopri